Company intelligence / Profile preview

Stratpharma

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

Stratpharma has developed and commercialized a portfolio of innovative topical medical devices—primarily film-forming gels that dry to form silicone gel sheets—for use in dermatology, plastic surgery, wound care, radiation oncology, scar management, stretch marks prevention/treatment, and women's intimate health. Their products are available in over 44 countries worldwide. The company is expanding its focus into oncology-related supportive care with products like StrataXRT for radiation dermatitis[1][4][5][6].

Therapeutic areas: Women's HealthDermatology
Modalities: Device
Industry: Consumable Medical Devices

Drug pipeline

7 assets

Stratamark

Commercial

Indications: Stretch marks

6 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Stratpharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stratpharma.

Explore the full profile